These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20646226)

  • 1. Optimizing clinical trial design for assessing the efficacy of functional foods.
    AbuMweis SS; Jew S; Jones PJ
    Nutr Rev; 2010 Aug; 68(8):485-99. PubMed ID: 20646226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance.
    Gallagher AM; Meijer GW; Richardson DP; Rondeau V; Skarp M; Stasse-Wolthuis M; Tweedie GC; Witkamp R;
    Br J Nutr; 2011 Nov; 106 Suppl 2():S16-28. PubMed ID: 22129661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific substantiation of claims in the USA: focus on functional foods.
    Lupton JR
    Eur J Nutr; 2009 Dec; 48 Suppl 1():S27-31. PubMed ID: 19937443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design considerations on the proof of efficacy of functional foods.
    Baldi I; Gregori D
    Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():43-50. PubMed ID: 21942855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PASSCLAIM - Synthesis and review of existing processes.
    Richardson DP; Affertsholt T; Asp NG; Bruce A; Grossklaus R; Howlett J; Pannemans D; Ross R; Verhagen H; Viechtbauer V
    Eur J Nutr; 2003 Mar; 42 Suppl 1():I96-111. PubMed ID: 12664324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and cancer: the disconnect between epidemiology and randomized clinical trials.
    Meyskens FL; Szabo E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the efficacy of functional food ingredients-introducing the concept "kinetics of biomarkers".
    Verhagen H; Coolen S; Duchateau G; Hamer M; Kyle J; Rechner A
    Mutat Res; 2004 Jul; 551(1-2):65-78. PubMed ID: 15225582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrigenomics approaches to functional foods.
    Ferguson LR
    J Am Diet Assoc; 2009 Mar; 109(3):452-8. PubMed ID: 19248861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
    Gulati OP; Berry Ottaway P
    Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual food components: functional food effects expressed as food components.
    Monro JA
    Eur J Clin Nutr; 2004 Feb; 58(2):219-30. PubMed ID: 14749740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and controversies in the design of obesity prevention trials.
    Stevens J; Taber DR; Murray DM; Ward DS
    Obesity (Silver Spring); 2007 Sep; 15(9):2163-70. PubMed ID: 17890483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.